115 related articles for article (PubMed ID: 11583024)
1. Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia.
Kolonics A; Apáti A; Nahajevszky S; Gáti R; Brózik A; Magócsi M
Haematologia (Budap); 2001; 31(2):125-38. PubMed ID: 11583024
[TBL] [Abstract][Full Text] [Related]
2. Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells.
Kolonics A; Apáti A ; Jánossy J; Brózik A; Gáti R; Schaefer A; Magócsi M
Cell Signal; 2001 Oct; 13(10):743-54. PubMed ID: 11602185
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome.
Hoefsloot LH; van Amelsvoort MP; Broeders LC; van der Plas DC; van Lom K; Hoogerbrugge H; Touw IP; Löwenberg B
Blood; 1997 Mar; 89(5):1690-700. PubMed ID: 9057652
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2.
Valk P; Verbakel S; von Lindern M; Löwenberg B; Delwel R
Hematol J; 2000; 1(4):254-63. PubMed ID: 11920199
[TBL] [Abstract][Full Text] [Related]
5. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
6. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor.
Rajotte D; Sadowski HB; Haman A; Gopalbhai K; Meloche S; Liu L; Krystal G; Hoang T
Blood; 1996 Oct; 88(8):2906-16. PubMed ID: 8874187
[TBL] [Abstract][Full Text] [Related]
7. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
[TBL] [Abstract][Full Text] [Related]
8. Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia.
Fuhler GM; Drayer AL; Vellenga E
Blood; 2003 Feb; 101(3):1172-80. PubMed ID: 12529294
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
[TBL] [Abstract][Full Text] [Related]
10. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
12. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
13. A distinct function of STAT proteins in erythropoietin signal transduction.
Kirito K; Uchida M; Yamada M; Miura Y; Komatsu N
J Biol Chem; 1997 Jun; 272(26):16507-13. PubMed ID: 9195960
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
Sui X; Krantz SB; You M; Zhao Z
Blood; 1998 Aug; 92(4):1142-9. PubMed ID: 9694701
[TBL] [Abstract][Full Text] [Related]
15. In vitro analysis of STAT5 activation by granulocyte-macrophage colony-stimulating factor.
Sakurai Y; Arai K; Watanabe S
Genes Cells; 2000 Nov; 5(11):937-947. PubMed ID: 11122381
[TBL] [Abstract][Full Text] [Related]
16. Definition of the role of tyrosine residues of the common beta subunit regulating multiple signaling pathways of granulocyte-macrophage colony-stimulating factor receptor.
Itoh T; Liu R; Yokota T; Arai KI; Watanabe S
Mol Cell Biol; 1998 Feb; 18(2):742-52. PubMed ID: 9447970
[TBL] [Abstract][Full Text] [Related]
17. Spleen tyrosine kinase mediates the actions of EPO and GM-CSF and coordinates with TGF-β in erythropoiesis.
Chang HC; Huang DY; Wu MS; Chu CL; Tzeng SJ; Lin WW
Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):687-696. PubMed ID: 28131718
[TBL] [Abstract][Full Text] [Related]
18. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V
Clin Cancer Res; 2012 Jun; 18(11):3079-89. PubMed ID: 22496271
[TBL] [Abstract][Full Text] [Related]
19. Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways.
Cárcamo JM; Bórquez-Ojeda O; Golde DW
Blood; 2002 May; 99(9):3205-12. PubMed ID: 11964284
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction pathways induced by GM-CSF in microglia: significance in the control of proliferation.
Liva SM; Kahn MA; Dopp JM; de Vellis J
Glia; 1999 Jun; 26(4):344-52. PubMed ID: 10383053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
